Home › Companies › ClearPoint Neuro, Inc. › 2025-2026

ClearPoint Neuro, Inc. 2025-2026 Proxy Voting Records

Compiled from SEC Form N-PX filings and ClearPoint Neuro, Inc.’s Form 8-K, filed 2026-05-21 (Item 5.07 on EDGAR). Page generated 04 October 2026.

  • 10Reported items
  • 117Asset managers
  • 1,138Fund votes
  • 2026-05-20Meeting date

Proxy season: 2023-2024 2025-2026

Explore ClearPoint Neuro, Inc. in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by ClearPoint Neuro, Inc.

These tallies are ClearPoint Neuro, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2026-05-21 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

ClearPoint Neuro, Inc. — official shareholder meeting results, meeting held 2026-05-20
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
Elect Director: Joseph M. Burnett 9,686,224---- 120,4599,991,790 Majority: yes
Elect Director: Lynnette C. Fallon 9,625,049---- 181,6349,991,790 Majority: yes
Elect Director: R. John Fletcher 9,676,332---- 130,3519,991,790 Majority: yes
Elect Director: B. Kristine Johnson 9,628,069---- 178,6149,991,790 Majority: yes
Elect Director: Matthew B. Klein 9,639,952---- 166,7319,991,790 Majority: yes
Elect Director: Linda M. Liau 9,601,872---- 204,8119,991,790 Majority: yes
Elect Director: Timothy T. Richards 9,639,577---- 167,1069,991,790 Majority: yes
Proposal 2: Ratification of Auditors. 19,296,33020,086482,057 --0 Majority: yes
Proposal 3: Advisory Approval of Executive Compensation. 8,825,126442,728538,829 --9,991,790 Passed
Proposal 4: Approval of the Seventh Amended and Restated 2013 Incentive Compensation Plan. 7,517,6341,793,261495,788 --9,991,790 Passed

Source: ClearPoint Neuro, Inc., Form 8-K, filed with the SEC on 2026-05-21 — read the filing on EDGAR.

How asset managers voted at the ClearPoint Neuro, Inc. 2025-2026 meeting

Each item below shows how the 117 asset managers that disclosed a ClearPoint Neuro, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of ClearPoint Neuro, Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. An advisory (non-binding) vote to approve the compensation of ClearPoint Neuro, Inc.'s named executive officers.

SECTION 14A SAY-ON-PAY VOTESCompany result: Passed

Combines 8 wordings of this item as funds reported it.

95% Passed · of votes cast

FOR 95%
FOR: 8,825,126AGAINST: 442,728

ClearPoint Neuro, Inc.’s own tally for this item (“Proposal 3: Advisory Approval of Executive Compensation.”): 8,825,126 for, 442,728 against — passed, per its Form 8-K filed 2026-05-21 (Item 5.07). Of all 29,989,563 outstanding shares: 29% for, 1% against (31% of the company cast a for/against vote).

The 117 asset managers below cast 95% of the shares they voted on this item FOR (3,685,385 for, 191,437 against).

FOR 95%
FOR: 3,685,385 (94.8%)AGAINST: 191,437 (4.9%)ABSTAIN: 6,649 (0.2%)NOT VOTED: 3,793 (0.1%)
Largest asset managers voting on “An advisory (non-binding) vote to approve the compensation of ClearPoint Neuro, Inc.'s named executive officer” at ClearPoint Neuro, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard1,476,5381 00For
BlackRock490,90683,129 00For
BROWN ADVISORY INC330,7270 00For
MAK CAPITAL ONE LLC302,1860 00For
State Street246,409523 00For
Charles Schwab159,1740 00For
Northern Trust111,410804 00For
Taylor Frigon Capital Management LLC99,1590 00For
GEODE CAPITAL MANAGEMENT, LLC70,1820 00For
Goldman Sachs41,3890 00For
MELLON INVESTMENTS Corp039,538 00Against
SILVERCREST ASSET MANAGEMENT GROUP LLC34,7000 00For
Fidelity31,1550 00For
BRADLEY FOSTER & SARGENT INC/CT28,6700 00For
STIFEL NICOLAUS & CO INC \MO\25,6920 00For
PARAMETRIC PORTFOLIO ASSOCIATES LLC21,1600 00For
Lincoln Financial17,9000 00For
UBS017,817 00Against
Equitable11,3646,400 00For
Invesco015,889 00Against
AllianceBernstein015,800 00Against
Global X12,4130 00For
John Hancock12,3830 00For
Corient Private Wealth LP11,2720 00For
Newton Investment Management North America, LLC9,7700 00For

Showing the 25 largest of 117 asset managers. See all 117 in the interactive database.

2. Approval of ClearPoint Neuro, Inc.'s Seventh Amended and Restated 2013 Incentive Compensation Plan.

COMPENSATIONCompany result: Passed

Combines 3 wordings of this item as funds reported it.

81% Passed · of votes cast

FOR 81%AGAINST 19%
FOR: 7,517,634AGAINST: 1,793,261

ClearPoint Neuro, Inc.’s own tally for this item (“Proposal 4: Approval of the Seventh Amended and Restated 2013 Incentive Compensation Plan.”): 7,517,634 for, 1,793,261 against — passed, per its Form 8-K filed 2026-05-21 (Item 5.07). Of all 29,989,563 outstanding shares: 25% for, 6% against (31% of the company cast a for/against vote).

The 33 asset managers below cast 97% of the shares they voted on this item FOR (1,692,391 for, 58,163 against).

FOR 96%
FOR: 1,692,391 (96.3%)AGAINST: 58,163 (3.3%)ABSTAIN: 6,650 (0.4%)
Largest asset managers voting on “Approval of ClearPoint Neuro, Inc.'s Seventh Amended and Restated 2013 Incentive Compensation Plan.” at ClearPoint Neuro, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard1,343,2252,127 10For
BlackRock170,4180 00For
Charles Schwab79,5870 00For
Fidelity26,2540 00For
Goldman Sachs21,7110 00For
Lincoln Financial017,900 00Against
Equitable11,3646,400 00For
Global X12,4130 00For
Pacific Life9,3810 00For
Brighthouse01 6,6490Abstain
John Hancock06,178 00Against
State Street86,091 00Against
Bridge Builder Trust5,1730 00For
AIG/SunAmerica04,077 00Against
SEI3,9000 00For
ProShares03,414 00Against
Nationwide3,2640 00For
DWS02,663 00Against
Principal02,263 00Against
Calvert02,225 00Against
Venerable Variable Insurance Trust2,1580 00For
Voya01,740 00Against
Invesco1,4760 00For
Northern Trust9810 00For
Brinker Capital Destinations Trust0818 00Against

Showing the 25 largest of 33 asset managers. See all 33 in the interactive database.

3. Election of Directors: B. Kristine Johnson

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 6 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 9,628,069WITHHELD: 178,614

ClearPoint Neuro, Inc.’s own tally for this item (“Elect Director: B. Kristine Johnson”): 9,628,069 for, 178,614 withheld, per its Form 8-K filed 2026-05-21 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 29,989,563 outstanding shares: 32% for, 0.6% withheld (33% of the company cast a for/withheld vote).

The 33 asset managers below cast 100% of the shares they voted on this item FOR (1,750,555 for, 0 against).

FOR 99.6%
FOR: 1,750,555 (99.6%)ABSTAIN: 6,649 (0.4%)
Largest asset managers voting on “Election of Directors: B. Kristine Johnson” at ClearPoint Neuro, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard1,345,3530 00For
BlackRock170,4180 00For
Charles Schwab79,5870 00For
Fidelity26,2540 00For
Goldman Sachs21,7110 00For
Lincoln Financial17,9000 00For
Equitable17,7640 00For
Global X12,4130 00For
Pacific Life9,3810 00For
Brighthouse10 6,6490Abstain
John Hancock6,1780 00For
State Street6,0990 00For
Bridge Builder Trust5,1730 00For
AIG/SunAmerica4,0770 00For
SEI3,9000 00For
ProShares3,4140 00For
Nationwide3,2640 00For
DWS2,6630 00For
Principal2,2630 00For
Calvert2,2250 00For
Venerable Variable Insurance Trust2,1580 00For
Voya1,7400 00For
Invesco1,4760 00For
Northern Trust9810 00For
Brinker Capital Destinations Trust8180 00For

Showing the 25 largest of 33 asset managers. See all 33 in the interactive database.

4. Election of Directors: Joseph M. Burnett

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 6 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 9,686,224WITHHELD: 120,459

ClearPoint Neuro, Inc.’s own tally for this item (“Elect Director: Joseph M. Burnett”): 9,686,224 for, 120,459 withheld, per its Form 8-K filed 2026-05-21 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 29,989,563 outstanding shares: 32% for, 0.5% withheld (33% of the company cast a for/withheld vote).

The 33 asset managers below cast 100% of the shares they voted on this item FOR (1,750,555 for, 0 against).

FOR 99.6%
FOR: 1,750,555 (99.6%)ABSTAIN: 6,649 (0.4%)
Largest asset managers voting on “Election of Directors: Joseph M. Burnett” at ClearPoint Neuro, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard1,345,3530 00For
BlackRock170,4180 00For
Charles Schwab79,5870 00For
Fidelity26,2540 00For
Goldman Sachs21,7110 00For
Lincoln Financial17,9000 00For
Equitable17,7640 00For
Global X12,4130 00For
Pacific Life9,3810 00For
Brighthouse10 6,6490Abstain
John Hancock6,1780 00For
State Street6,0990 00For
Bridge Builder Trust5,1730 00For
AIG/SunAmerica4,0770 00For
SEI3,9000 00For
ProShares3,4140 00For
Nationwide3,2640 00For
DWS2,6630 00For
Principal2,2630 00For
Calvert2,2250 00For
Venerable Variable Insurance Trust2,1580 00For
Voya1,7400 00For
Invesco1,4760 00For
Northern Trust9810 00For
Brinker Capital Destinations Trust8180 00For

Showing the 25 largest of 33 asset managers. See all 33 in the interactive database.

5. Election of Directors: Linda M. Liau

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 6 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 9,601,872WITHHELD: 204,811

ClearPoint Neuro, Inc.’s own tally for this item (“Elect Director: Linda M. Liau”): 9,601,872 for, 204,811 withheld, per its Form 8-K filed 2026-05-21 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 29,989,563 outstanding shares: 32% for, 0.7% withheld (33% of the company cast a for/withheld vote).

The 33 asset managers below cast 100% of the shares they voted on this item FOR (1,748,274 for, 0 against).

FOR 99.4%
FOR: 1,748,274 (99.5%)ABSTAIN: 8,930 (0.5%)
Largest asset managers voting on “Election of Directors: Linda M. Liau” at ClearPoint Neuro, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard1,343,2300 2,1230For
BlackRock170,4180 00For
Charles Schwab79,5870 00For
Fidelity26,2540 00For
Goldman Sachs21,7110 00For
Lincoln Financial17,9000 00For
Equitable17,7640 00For
Global X12,4130 00For
Pacific Life9,3810 00For
Brighthouse10 6,6490Abstain
John Hancock6,1780 00For
State Street6,0920 70For
Bridge Builder Trust5,1730 00For
AIG/SunAmerica4,0770 00For
SEI3,9000 00For
ProShares3,4140 00For
Nationwide3,2640 00For
DWS2,6630 00For
Principal2,2630 00For
Calvert2,2250 00For
Venerable Variable Insurance Trust2,1580 00For
Voya1,7400 00For
Invesco1,4760 00For
Northern Trust9810 00For
Brinker Capital Destinations Trust8180 00For

Showing the 25 largest of 33 asset managers. See all 33 in the interactive database.

6. Election of Directors: Lynnette C. Fallon

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 6 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 9,625,049WITHHELD: 181,634

ClearPoint Neuro, Inc.’s own tally for this item (“Elect Director: Lynnette C. Fallon”): 9,625,049 for, 181,634 withheld, per its Form 8-K filed 2026-05-21 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 29,989,563 outstanding shares: 32% for, 0.7% withheld (33% of the company cast a for/withheld vote).

The 33 asset managers below cast 100% of the shares they voted on this item FOR (1,745,059 for, 0 against).

FOR 99.3%
FOR: 1,745,059 (99.3%)ABSTAIN: 12,145 (0.7%)
Largest asset managers voting on “Election of Directors: Lynnette C. Fallon” at ClearPoint Neuro, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard1,342,2390 3,1140For
BlackRock170,4180 00For
Charles Schwab79,5870 00For
Fidelity26,2540 00For
Goldman Sachs21,7110 00For
Lincoln Financial17,9000 00For
Equitable17,7640 00For
Global X12,4130 00For
Pacific Life9,3810 00For
Brighthouse10 6,6490Abstain
John Hancock6,1780 00For
State Street6,0920 70For
Bridge Builder Trust5,1730 00For
AIG/SunAmerica4,0770 00For
SEI3,9000 00For
ProShares3,4140 00For
Nationwide3,2640 00For
DWS2,6630 00For
Principal2,2630 00For
Calvert00 2,2250Abstain
Venerable Variable Insurance Trust2,1580 00For
Voya1,7400 00For
Invesco1,4760 00For
Northern Trust9810 00For
Brinker Capital Destinations Trust8180 00For

Showing the 25 largest of 33 asset managers. See all 33 in the interactive database.

7. Election of Directors: Matthew B. Klein

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 6 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 9,639,952WITHHELD: 166,731

ClearPoint Neuro, Inc.’s own tally for this item (“Elect Director: Matthew B. Klein”): 9,639,952 for, 166,731 withheld, per its Form 8-K filed 2026-05-21 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 29,989,563 outstanding shares: 32% for, 0.6% withheld (33% of the company cast a for/withheld vote).

The 33 asset managers below cast 100% of the shares they voted on this item FOR (1,750,555 for, 0 against).

FOR 99.6%
FOR: 1,750,555 (99.6%)ABSTAIN: 6,649 (0.4%)
Largest asset managers voting on “Election of Directors: Matthew B. Klein” at ClearPoint Neuro, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard1,345,3530 00For
BlackRock170,4180 00For
Charles Schwab79,5870 00For
Fidelity26,2540 00For
Goldman Sachs21,7110 00For
Lincoln Financial17,9000 00For
Equitable17,7640 00For
Global X12,4130 00For
Pacific Life9,3810 00For
Brighthouse10 6,6490Abstain
John Hancock6,1780 00For
State Street6,0990 00For
Bridge Builder Trust5,1730 00For
AIG/SunAmerica4,0770 00For
SEI3,9000 00For
ProShares3,4140 00For
Nationwide3,2640 00For
DWS2,6630 00For
Principal2,2630 00For
Calvert2,2250 00For
Venerable Variable Insurance Trust2,1580 00For
Voya1,7400 00For
Invesco1,4760 00For
Northern Trust9810 00For
Brinker Capital Destinations Trust8180 00For

Showing the 25 largest of 33 asset managers. See all 33 in the interactive database.

8. Election of Directors: R. John Fletcher

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 6 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 9,676,332WITHHELD: 130,351

ClearPoint Neuro, Inc.’s own tally for this item (“Elect Director: R. John Fletcher”): 9,676,332 for, 130,351 withheld, per its Form 8-K filed 2026-05-21 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 29,989,563 outstanding shares: 32% for, 0.5% withheld (33% of the company cast a for/withheld vote).

The 33 asset managers below cast 100% of the shares they voted on this item FOR (1,747,339 for, 0 against).

FOR 99.4%
FOR: 1,747,339 (99.4%)ABSTAIN: 9,865 (0.6%)
Largest asset managers voting on “Election of Directors: R. John Fletcher” at ClearPoint Neuro, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard1,344,3620 9910For
BlackRock170,4180 00For
Charles Schwab79,5870 00For
Fidelity26,2540 00For
Goldman Sachs21,7110 00For
Lincoln Financial17,9000 00For
Equitable17,7640 00For
Global X12,4130 00For
Pacific Life9,3810 00For
Brighthouse10 6,6490Abstain
John Hancock6,1780 00For
State Street6,0990 00For
Bridge Builder Trust5,1730 00For
AIG/SunAmerica4,0770 00For
SEI3,9000 00For
ProShares3,4140 00For
Nationwide3,2640 00For
DWS2,6630 00For
Principal2,2630 00For
Calvert00 2,2250Abstain
Venerable Variable Insurance Trust2,1580 00For
Voya1,7400 00For
Invesco1,4760 00For
Northern Trust9810 00For
Brinker Capital Destinations Trust8180 00For

Showing the 25 largest of 33 asset managers. See all 33 in the interactive database.

9. Election of Directors: Timothy T. Richards

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 6 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 9,639,577WITHHELD: 167,106

ClearPoint Neuro, Inc.’s own tally for this item (“Elect Director: Timothy T. Richards”): 9,639,577 for, 167,106 withheld, per its Form 8-K filed 2026-05-21 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 29,989,563 outstanding shares: 32% for, 0.6% withheld (33% of the company cast a for/withheld vote).

The 33 asset managers below cast 100% of the shares they voted on this item FOR (1,746,050 for, 0 against).

FOR 99.3%
FOR: 1,746,050 (99.4%)ABSTAIN: 11,154 (0.6%)
Largest asset managers voting on “Election of Directors: Timothy T. Richards” at ClearPoint Neuro, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard1,343,2310 2,1220For
BlackRock170,4180 00For
Charles Schwab79,5870 00For
Fidelity26,2540 00For
Goldman Sachs21,7110 00For
Lincoln Financial17,9000 00For
Equitable17,7640 00For
Global X12,4130 00For
Pacific Life9,3810 00For
Brighthouse10 6,6490Abstain
John Hancock6,1780 00For
State Street6,0920 70For
Bridge Builder Trust5,1730 00For
AIG/SunAmerica4,0770 00For
SEI3,9000 00For
ProShares3,4140 00For
Nationwide3,2640 00For
DWS2,6630 00For
Principal2,2630 00For
Calvert00 2,2250Abstain
Venerable Variable Insurance Trust2,1580 00For
Voya1,7400 00For
Invesco1,4760 00For
Northern Trust9810 00For
Brinker Capital Destinations Trust8180 00For

Showing the 25 largest of 33 asset managers. See all 33 in the interactive database.

10. Ratification of the appointment of Cherry Bekaert LLP as ClearPoint Neuro, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2026.

AUDIT-RELATED

Combines 3 wordings of this item as funds reported it.

99.9% fund support · no official result

FOR 99.6%

The 33 asset managers below cast 99.9% of the shares they voted on this item FOR (1,750,554 for, 0 against).

FOR: 1,750,554 (99.6%)AGAINST: 0 (0.0%)ABSTAIN: 6,650 (0.4%)
Largest asset managers voting on “Ratification of the appointment of Cherry Bekaert LLP as ClearPoint Neuro, Inc.'s independent registered publi” at ClearPoint Neuro, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard1,345,3520 10For
BlackRock170,4180 00For
Charles Schwab79,5870 00For
Fidelity26,2540 00For
Goldman Sachs21,7110 00For
Lincoln Financial17,9000 00For
Equitable17,7640 00For
Global X12,4130 00For
Pacific Life9,3810 00For
Brighthouse10 6,6490Abstain
John Hancock6,1780 00For
State Street6,0990 00For
Bridge Builder Trust5,1730 00For
AIG/SunAmerica4,0770 00For
SEI3,9000 00For
ProShares3,4140 00For
Nationwide3,2640 00For
DWS2,6630 00For
Principal2,2630 00For
Calvert2,2250 00For
Venerable Variable Insurance Trust2,1580 00For
Voya1,7400 00For
Invesco1,4760 00For
Northern Trust9810 00For
Brinker Capital Destinations Trust8180 00For

Showing the 25 largest of 33 asset managers. See all 33 in the interactive database.

Largest ClearPoint Neuro, Inc. shareholders voting in 2025-2026

Ranked by the number of ClearPoint Neuro, Inc. shares each manager voted on the most widely held ballot item of the 2025-2026 meeting, shown as a share of the 29,989,563 shares outstanding at the time of that meeting.

Top ClearPoint Neuro, Inc. shareholders by shares voted, 2025-2026
#Asset manager % of shares outstanding
1Vanguard 4.92%
2BlackRock 1.91%
3BROWN ADVISORY INC 1.10%
4MAK CAPITAL ONE LLC 1.01%
5State Street 0.82%
6Charles Schwab 0.53%
7Northern Trust 0.37%
8Taylor Frigon Capital Management LLC 0.33%
9GEODE CAPITAL MANAGEMENT, LLC 0.23%
10Goldman Sachs 0.14%

Reported ClearPoint Neuro, Inc. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

ClearPoint Neuro, Inc. beneficial owners on record for the 2025-2026 proxy season
Holder % outstanding Disclosure
MAK CAPITAL ONE LLC 7.92% 13G
Bigger Michael 7.58% 13G
Bigger Capital Fund, LP 7.39% DEF14A
BlackRock 6.94% 13F
Vanguard Group 5.89% 13F
Joseph M. Burnett 2.87% DEF14A
Geode Capital 2.35% 13F
State Street 2.27% 13F
Goldman Sachs 1.55% 13F
Millennium Management 0.77% 13F

Percentages above are of 29,989,563 shares outstanding, as reported by ClearPoint Neuro, Inc. on its Form 10-Q dated 2026-05-07 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from ClearPoint Neuro, Inc.’s 10-Q dated 2026-05-07. This page is a static snapshot rebuilt weekly on 04 October 2026; a live search always shows the current data.

At ClearPoint Neuro, Inc.'s shareholder meeting held 2026-05-20, in the 2025-2026 proxy season, 117 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,138 separate fund positions. Their filings are grouped here into 10 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — An advisory (non-binding) vote to approve the compensation of ClearPoint Neuro, Inc.'s named… — the proposal passed with 95% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: ClearPoint Neuro, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2026-05-21.

ClearPoint Neuro, Inc. proxy season coverage: 2023-2024 · 2025-2026 (this page).